Showing 2081-2090 of 7866 results for "".
MYDON by Quantel Derma - Perfect for Spider Veins
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/mydon-by-quantel-derma-perfect-for-spider-veins/19375/The Nd:YAG laser system is the ideal treatment solution for vascular skin changes such as spider veins or varicosis. With proven 1064 nm wavelength and integrated contact cooling before, during and after each laser pulse. The effective Burst Mode lets you treat vessels of up to 5 mm. Various handpieLaser Skin Rejuvenation
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/laser-skin-rejuvenation/19408/Dr. Amy Derick reviews the latest in lasers for improving skin tone, texture and laxity.How to Choose the Right Filler
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/how-to-choose-the-right-filler/19411/Dr. Amy Derick reviews key points about injectable fillers, a non-invasive alternative to surgical facelifts.Dr. Chan Discusses Experience with Gemini Laser
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dr-chan-discusses-experience-with-gemini-laser/19471/“Gemini is an extremely effective non-ablative skin rejuvenation laser. And by combining the 532 KTP lasers with the long pulse 1064 YAG, we can achieve non-ablative skin rejuvenations in terms of reductions of pigmentations, fine lines, pore size and vessel improvement.” & #8212Professor HenryPushing the Envelope in PN Research
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37181/Raja Sivamani, MD, MS, AP, an integrative dermatologist and Adjunct Associate Professor of Clinical Dermatology at the University of California, Davis, discusses how research to help understand different aspects of prurigo nodularis can help develop therapeutics that can be life-changing for patientGalderma FCBCure SoS Hub Chovatiya Video 2
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/galderma-fcbcure-sos-hub-chovatiya-video-2/56736/Raj Chovatiya, MD, PhD, MSCI, FAAD, discusses whether barrier dysfunction drives inflammation and immune dysregulation, or vice versa, or both, in atopic dermatitis.The Case for Prioritizing Patient Reacquisition
https://practicaldermatology.com/series/c-suite-chats/the-case-for-prioritizing-patient-reacquisition/56424/Susie Kozlowski, Business Development Manager for Brevium, explains the importance of patient reacquisition for a dermatology practice.Coding for Superficial Radiation Therapy
https://practicaldermatology.com/series/c-suite-chats/coding-for-superficial-radiation-therapy/56364/Joseph C. Sardano, Chairman and CEO of Sensus Healthcare, discusses the issue of insurance denials for noninvasive skin cancer treatments such as superficial radiation therapy (SRT), and a new solution for ensuring predictable payment.Commitment to Clinical Evidence in Regenerative Aesthetics
https://practicaldermatology.com/series/c-suite-chats/commitment-to-clinical-evidence-in-regenerative-aesthetics/54693/Laura Ellis, MD, CEO and Co-Founder of LevEllis, Inc., discusses the current state of aesthetic regenerative medicine and the importance of clinical evidence as the field continues to advance.Connections for the Future of Dermatology
https://practicaldermatology.com/series/skin-minute/connections-for-the-future-of-dermatology/54688/Frederick Beddingfield, MD, PhD, recaps the Dermatology Summit 2026, a meeting to connect innovators and investors in the field of dermatology.